Retrieve Medical Holdings PE Ratio 2012-2025 | RMHI
Current and historical p/e ratio for Retrieve Medical Holdings (RMHI) from 2012 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Retrieve Medical Holdings PE ratio as of April 21, 2026 is 0.00.
| Retrieve Medical Holdings PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2026-04-21 | 1.00 | 0.00 | |
| 2025-09-30 | 1.30 | $-0.08 | 0.00 |
| 2025-06-30 | 1.08 | $-0.09 | 0.00 |
| 2025-03-31 | 4.50 | $-0.15 | 0.00 |
| 2024-12-31 | 1.07 | $-0.16 | 0.00 |
| 2024-09-30 | 2.57 | $0.24 | 10.71 |
| 2024-06-30 | 2.20 | $0.24 | 9.17 |
| 2024-03-31 | 3.70 | $0.29 | 12.76 |
| 2023-12-31 | 1.73 | $-0.19 | 0.00 |
| 2023-09-30 | 3.95 | $-0.59 | 0.00 |
| 2023-06-30 | 2.75 | $-0.65 | 0.00 |
| 2023-03-31 | 3.77 | $-0.78 | 0.00 |
| 2022-12-31 | 27.60 | $-0.40 | 0.00 |
| 2022-09-30 | 12.00 | $-0.40 | 0.00 |
| 2022-06-30 | 11.00 | $-0.31 | 0.00 |
| 2022-03-31 | 16.00 | $-0.14 | 0.00 |
| 2021-12-31 | 16.20 | $-0.11 | 0.00 |
| 2021-09-30 | 26.00 | $-0.11 | 0.00 |
| 2021-06-30 | 23.40 | $-0.11 | 0.00 |
| 2021-03-31 | 28.00 | $-0.12 | 0.00 |
| 2020-12-31 | 16.60 | $-0.02 | 0.00 |
| 2020-09-30 | 2.40 | $-0.02 | 0.00 |
| 2020-06-30 | 3.00 | $-0.02 | 0.00 |
| 2020-03-31 | 2.80 | $-0.01 | 0.00 |
| 2019-12-31 | 2.60 | 0 | 0.00 |
| 2019-09-30 | 2.40 | 0 | 0.00 |
| 2019-06-30 | 7.40 | 0 | 0.00 |
| 2019-03-31 | 18.60 | 0 | 0.00 |
| 2018-12-31 | 24.00 | 0 | 0.00 |
| 2018-09-30 | 25.00 | 0 | 0.00 |
| 2018-06-30 | 28.80 | 0 | 0.00 |
| 2018-03-31 | 17.80 | 0 | 0.00 |
| 2017-12-31 | 30.00 | 0 | 0.00 |
| 2017-09-30 | 5.80 | 0 | 0.00 |
| 2017-06-30 | 7.40 | 0 | 0.00 |
| 2017-03-31 | 11.20 | 0 | 0.00 |
| 2016-12-31 | 8.00 | 0 | 0.00 |
| 2016-09-30 | 6.00 | 0 | 0.00 |
| 2016-06-30 | 3.40 | 0 | 0.00 |
| 2016-03-31 | 2.40 | 0 | 0.00 |
| 2015-12-31 | 5.40 | $-2.00 | 0.00 |
| 2015-09-30 | 10.00 | $-4.00 | 0.00 |
| 2015-06-30 | 23.20 | $-4.00 | 0.00 |
| 2015-03-31 | 46.00 | $-8.00 | 0.00 |
| 2014-12-31 | 39.60 | $-8.00 | 0.00 |
| 2014-09-30 | 102.00 | $-8.00 | 0.00 |
| 2014-06-30 | 188.00 | $-8.00 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.028B | $0.000B |
| Retrieve Medical Inc. is a software company. It is commercializing a patented Clinical Documentation Improvement platform, Retrieve Dx(TM), which enhances physician ability to quickly understand the complex clinical history of patients and diagnose chronic conditions by analyzing physician notes, lab results, radiology reports, EKG interpretations and more. Retrieve Medical Inc., formerly known as Peak Pharmaceuticals Inc., is based in SCOTTSDALE, AZ. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $24.733B | 27.19 |
| Tempus AI (TEM) | United States | $7.677B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $4.429B | 38.86 |
| Doximity (DOCS) | United States | $3.888B | 16.84 |
| IRhythm Holdings (IRTC) | United States | $3.724B | 0.00 |
| 10x Genomics (TXG) | United States | $2.973B | 0.00 |
| Privia Health (PRVA) | United States | $2.810B | 131.59 |
| Hinge Health (HNGE) | United States | $2.789B | 0.00 |
| Heartflow (HTFL) | United States | $2.311B | 0.00 |
| Omnicell (OMCL) | United States | $1.564B | 43.00 |
| Inspire Medical Systems (INSP) | United States | $1.555B | 20.94 |
| Enovis (ENOV) | United States | $1.405B | 7.40 |
| Butterfly Network (BFLY) | United States | $1.047B | 0.00 |
| Azenta (AZTA) | United States | $1.023B | 41.13 |
| Clover Health Investments (CLOV) | United States | $1.013B | 0.00 |
| Talkspace (TALK) | United States | $0.864B | 103.40 |
| Schrodinger (SDGR) | United States | $0.839B | 0.00 |
| Phreesia (PHR) | United States | $0.490B | 50.38 |
| Fulgent Genetics (FLGT) | United States | $0.429B | 0.00 |
| Standard BioTools (LAB) | United States | $0.345B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.322B | 0.00 |
| CapsoVision (CV) | United States | $0.311B | 0.00 |
| Senseonics Holdings (SENS) | United States | $0.279B | 0.00 |
| Claritev (CTEV) | United States | $0.269B | 0.00 |
| TruBridge (TBRG) | United States | $0.268B | 8.60 |
| Evolent Health (EVH) | United States | $0.260B | 0.00 |
| Carlsmed (CARL) | United States | $0.239B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.196B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.189B | 0.00 |
| CareCloud (CCLD) | United States | $0.115B | 8.18 |
| Nyxoah SA (NYXH) | Belgium | $0.111B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.102B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.101B | 0.00 |
| American Well (AMWL) | United States | $0.086B | 0.00 |
| Outset Medical (OM) | United States | $0.077B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.073B | 0.00 |
| Pulmonx (LUNG) | United States | $0.058B | 0.00 |
| 111 (YI) | China | $0.057B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.052B | 0.00 |
| Precipio (PRPO) | United States | $0.049B | 0.00 |
| HeartBeam (BEAT) | United States | $0.047B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.034B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.020B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.018B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.017B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.011B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.009B | 0.00 |
| Zhongchao (ZCMD) | China | $0.008B | 0.00 |
| HeartSciences (HSCS) | United States | $0.007B | 0.00 |
| ITonic Holdings (ITOC) | China | $0.005B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.002B | 0.00 |
| PROFUSA (PFSA) | United States | $0.001B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.001B | 0.00 |